
Phase 3 OptIMMize-1 findings show sustained skin clearance, itch reduction, and quality-of-life improvements with risankizumab through 52 weeks.
Washington D.C. - By remaining aware of female patients' non-dermatologic medical issues, dermatologists can offer a suitable acne medication that will address oral contraception, as well, according to Moneera Haque.






